The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein

Genes and Development

Volumn 12, Issue 22, 1998, Pages 3512-3527

  Garber, Mitchell E ^a,b   Wei, Ping ^a   KewalRamani, Vineet N ^d   Mayall, Timothy P ^a   Herrmann, Christine H ^e   Rice, Andrew P ^e   Littman, Dan R ^c,d   Jones, Katherine A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclin T1; HIV 1 Tat; HIV 1 transcription; RNA binding protein; TAK P TEFb; TAR ; Zinc binding protein

Indexed keywords

CYCLINE; RNA BINDING PROTEIN; ZINC;

ANIMAL CELL; ARTICLE; GENETIC CONSERVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; RNA VIRUSES;

EID: 0032533253     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.22.3512     Document Type: Article

References (65)

1. Adamczewski, J., M. Rossignol, J. Tassan, E. Nigg, V. Moncollin, and J.-M. Egly. 1996. MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH. EMBO J. 15: 1877-1884.
2. Alonso, A., T. Cujec, and B.M. Peterlin. 1994. Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J. Virol. 68: 6505-6513.
3. Andersen, G., D. Busso, A. Poterszman, J. Hwang, J.-M. Wurtz, R. Ripp, J.-C. Thierry, J.-M. Egly, and D. Moras. 1997. The structure of cyclin H: Common mode of kinase activation and specific features. EMBO J. 16: 958-967.
4. Bagby, S., S. Kim, E. Maldonado, K. Tong, D. Reinberg, and M. Ikura. 1995. Solution structure of the carboxy-terminal core domain of human TFIIB: Similarity to cyclin A and interaction with TATA-binding protein. Cell 82: 857-867.
5. Bartz, S. and M. Vodicka. 1997. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12: 337-342.
6. Canivet, M., A.D. Hoffman, D. Hardy, J. Sernatinger, and J.A. Levy. 1990. Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses. Virology 178: 543-551.
7. Cullen, B.R. 1998. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell 93: 685-692.
8. Deng, H., D. Unutmaz, V. KewalRamani, and D. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388: 296-300.
9. Dingwall, C., I. Ernberg, M.J. Gait, S.M. Green, S. Heaphy, J. Karn, A.D. Lowe, M. Singh, and M.A. Skinner. 1990. HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9: 4145-4153.
10. Emerman, M. and M. Malim. 1998. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology. Science 280: 1880-1884.
11. Frankel, A., D. Bredt, and C. Pabo. 1988a. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240: 70-73.
12. Frankel, A., L. Chen, R. Cotter, and C. Pabo. 1988b. Dimerization of the tat protein from human immunodeficiency virus: A cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc. Natl. Acad. Sci. 85: 6297-6300.
13. Fujinaga, K., T.P. Cujec, J. Peng, J. Garriga, D.H. Price, X. Grana, and B.M. Peterlin. 1998. The ability of positive transcription elongation factor b to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, Cyclin T1, and Tat. J. Virol. 72: 7154-7159.
14. Gait, M. and J. Karn. 1993. RNA recognition by the human immunodeficiency virus Tat and Rev proteins. Trends Biochem. Sci. 18: 255-259.
15. Garber, M.E., P. Wei, and K.A. Jones. 1998. HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harbor Symp. Quant. Biol. 63: (in press).
16. Garcia-Martinez, L.F., G. Mavanka, J.M. Neveu, W.S. Lane, D. Ivanov, and R.B. Gaynor. 1997. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16: 2836-2850.
17. Gold, M.O., X. Yang, C.H. Herrmann, and A.P. Rice. 1998. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol. 72: 4448-4453.
18. Grana, X., A. De Luca, N. Sang, Y. Fu, P. Claudio, J. Rosenblatt, D. Morgan, and A. Giordano. 1994. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retino blastoma protein in vitro. Proc. Natl. Acad. Sci. 91: 3834-3838.
19. Hart, C., J. Galphin, M. Westhafer, and G. Schochetman. 1993. TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. J. Virol. 67: 5020-5024.
20. Hart, C., C. Ou, J. Galphin, J. Moore, L. Bacheler, J. Wasmuth, S. Petteway, Jr., and G. Schochetman. 1989. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 246: 488-491.
21. Hartzog, G.A., T. Wada, H. Handa, and F. Winston. 1998. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes & Dev. 12: 357-369.
22. Herrmann, C.H. and A.P. Rice. 1993. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197: 601-608.
23. _. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69: 1612-1620.
24. Herrmann, C.H., R.G. Carroll, P. Wei, K.A. Jones, and A.P. Rice. 1998. Tat-associated kinase, TAK, activity is regulated by distinct mechanism in peripheral blood lymphocytes and promonocytic cell lines. J. Virol (in press).
25. Himathongkham, S. and P.A. Luciw. 1996. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219: 485-488.
26. Huang, H.W. and K.T. Wang. 1996. Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein. Biochem. Biophys. Res. Comm. 227: 615-621.
27. Huang, M., A. Maynard, J.A. Turpin, L. Graham, G.M. Janini, D.G. Covell, and W.G. Rice. 1998. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins. J. Med. Chem. 41: 1371-1381.
28. Jeffrey, P., A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 367: 313-320.
29. Jones, K.A. 1997. Taking a new TAK on Tat transactivation. Genes & Dev. 11: 2593-2599.
30. Kim, K.K., H.M. Chamberlin, D.O. Morgan and S.-H. Kim. 1996. Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase. Nat. Struct. Biol. 3: 849-855.
31. Lee, J.-O., A. Russo, and N. Pavletich. 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391: 859-865.
32. Luo, Y., S. Madore, T. Parslow, B.R. Cullen, and B.M. Peterlin. 1993. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J. Virol. 67: 5617-5622.
33. Madore, S. and B.R. Cullen. 1993. Genetic analysis of the co-factor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67: 3703-3711.
34. Mancebo, H., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes & Dev. 11: 2633-2644.
35. Marshall, N., J. Peng, Z. Xie, and D.H. Price. 1996. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271: 27176-27183.
36. Marshall, N. and D.H. Price. 1992. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12: 2078-2090.
37. _. 1995. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270: 12335-12338.
38. Martin-Castellanos, C. and S. Moreno. 1997. Recent advances on cyclins, CDKs and CDK inhibitors. Trends Cell Biol. 7: 95-98.
39. McDonnell, N., R. De Guzman, W. Rice, J. Turpin, and M. Summers. 1997. Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS. J. Med. Chem. 40: 1969-1976.
40. Morgenstern, J. and H. Land. 1990. Advanced mammalian gene transfer: High titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
41. Nikolov, D., H. Chen, E. Halay, A. Usheva, K. Hisatake, D.K. Lee, R.G. Roeder, and S. Burley. 1995. Crystal structure of a TFIIB-TBP-TATA element ternary complex. Nature 377: 119-127.
42. Noble, M., J. Endicott, N. Brown, and L. Johnson. 1997. The cyclin box fold: Protein recognition in cell-cycle and transcriptional control. Trends Biochem. Sci. 22: 482-487.
43. Parada, C. and R.G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxyl-terminal domain. Nature 384: 375-378.
44. Peng, J., N. Marshall, and D.H. Price. 1998a. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J. Biol. Chem. 273: 13855-13860.
45. Peng, J., Y. Zhu, J. Milton, and D.H. Price. 1998b. Identification of multiple cyclin subunits of human P-TEFb. Genes & Dev. 12: 755-762.
46. Peterson, S.R., A. Dvir, C.W. Anderson and W.S. Dynan. 1992. DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. Genes & Dev. 6: 426-438.
47. Rice, A.P. and F. Chan. 1991. Tat protein of human immunodeficiency virus type 1 is a monomer when expressed in mammalian cells. Virology 185: 451-454.
48. Rice, W., C. Schaeffer, B. Harten, F. Villinger, T. South, M. Summers, L. Henderson, J. Bess, Jr, L. Arthur, J. McDougal et al. 1993. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 361: 473-475.
49. Rice, W., J. Supko, L. Malspeis, R. Buckheit, Jr., D. Clanton, M. Bu, L. Graham, C. Schaeffer, J. Turpin, J. Domagala et al. 1995. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270: 1194-1197.
50. Rossignol, M., I. Kolb-Cheynel, and J.-M. Egly. 1997. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J. 16: 1628-1637.
51. Russo, A., P. Jeffrey, A. Patten, J. Massague, and N. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382: 325-331.
52. Sadaie, M., R. Mukhopadhyaya, Z. Benaissa, G. Pavlakis, and F. Wong-Staal. 1990. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication. AIDS Res. Hum. Retroviruses 6: 1257-1263.
53. Shibata, R., M. Kawamura, H. Sakai, M. Hayami, A. Ishimoto, and A. Adachi. 1991. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65: 3514-3520.
54. Tanaka, M. and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation. Cell 60: 375-386.
55. Tassan, J., M. Jaquenoud, A. Fry, S. Frutiger, G. Hughes, and E. Nigg. 1995. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J. 14: 5608-5617.
56. Trkola, A., T. Ketas, V. KewalRamani, F. Endorf, J. Binley, H. Katinger, J. Robinson, D. Littman, and J. Moore. 1998. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J. Virol. 72: 1876-1885.
57. Trono, D. and D. Baltimore. 1990. A human cell factor is essential for HIV-1 Rev action. EMBO J. 9: 4155-4160.
58. Wada, T., T. Toshiyuki, Y. Yamaguchi, A. Ferdous, T. Imai, S. Hirose, S. Sugimoto, K. Yano, G.A. Hartzog, F. Winston, S. Buratowski, and H. Handa. 1998. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes & Dev. 12: 343-356.
59. Wei, P., M.E. Garber, S.-M. Fang, W.H. Fischer, and K.A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451-462.
60. Wu-Baer, F., W.S. Lane, and R.B. Gaynor. 1998. Role of the human homolog of the yeast transcription factor Spt5 in HIV-1 Tat-activation. J. Mol. Biol. 277: 179-197.
61. Yang, X., M. Gold, D. Tang, D. Lewis, E. Aguilar-Cordova, A.P. Rice, and C.H. Herrmann. 1997. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. 94: 12331-12336.
62. Yang, X., C.H. Herrmann, and A.P. Rice. 1996. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70: 4576-4584.
63. Yankulov, K. and D. Bentley. 1997. Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16: 1638-1646.
64. Zhou, Q., D. Chen, E. Pierstorff, and K. Luo. 1998. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17: 3681-3691.
65. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. Mathews, and D.H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes & Dev. 11: 2622-2632.